PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Neoleukin Therapeutics Inc., Seattle, WA, USA.\', \'School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China.\', \'Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.\', \'Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, USA.\', \'Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.\', \'Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Department of Microbiology, University of Washington, Seattle, WA, USA.\', \'Department of Infectious Diseases, University of Georgia, Athens, GA, USA.\', \'Neoleukin Therapeutics Inc., Seattle, WA, USA. dadriano@neoleukin.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/science.abe0075
?:doi
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 33154107
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33154107>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33154107>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all